Luliconazole
Overview
Luliconazole is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2105689).
API suppliers (6)
Suppliers of Luliconazole evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 5 of 6 suppliers.
3 of 6 hold a GMP certificate on record in the EU or UK registers
- HAMARI PFST LTD1 active DMF
- ALIVUS LIFE SCIENCES LTDIndia1 active DMF GMP on record
- Taro Pharmaceutical Industries Ltd.Israel1 active DMF GMP on record
- MAITHRI DRUGS PRIVATE LTDIndia1 active DMF GMP on record
- KATAYAMA SEIYAKUSYO CO., LTD.Japan
- Viwit Pharmaceutical Co., Ltd.China
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Luliconazole expires 28 Apr 2034. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile
- Canonical SMILES
- C1[C@H](S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl
- InChIKey
- YTAOBBFIOAEMLL-REQDGWNSSA-N
Do you supply Luliconazole? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.